Gas Chromatography/Mass Spectrometry-Based Metabonomics - Proteomic and Metabolomic Approaches to Biomarker Discovery - page 139

ight mass spectrometry. Anal Bioanal Chem
2010; 398 (3):1285 e 93.
35. Chan ECY, Koh PK, Mal M, Cheah PY, Eu KW,
Backshall A, et al. Metabolic pro

time-of- ionization quadrupole mass spectrometry. Anal Chem

2010; 82 (15):6480 e 6.
47. Begley P, Francis-McIntyre S, Dunn WB, Broadhurst DI,
Halsall A, Tseng A, et al. Development and perfor-
mance of a gas chromatography-time-of-

ling of human
colorectal cancer using high-resolution magic angle
spinning nuclear magnetic resonance (HR-MAS NMR)
spectroscopy and gas chromatography mass spec-
trometry (GC/MS). JProteomeRes 2009; 8 (1):352 e 61.
36. Mal M, Koh PK, Cheah PY, Chan ECY. Development
and validation of a gas chromatography/mass spec-
trometry method for the metabolic pro

ight mass
spectrometry analysis for large-scale nontargeted
metabolomic studies of human serum. Anal Chem 2009;
81 (16):7038 e 46.
48. Sangster T, Major H, Plumb R, Wilson AJ,
Wilson ID. A pragmatic and readily implemented
quality control strategy for HPLC-MS and GC-MS-
based metabonomic analysis. Analyst 2006; 131 (10):
1075 e 8.
49. Koek MM, Jellema RH, van der Greef J, Tas AC,
Hankemeier T. Quantitative metabolomics based on
gas chromatography mass spectrometry: Status and
perspectives. Metabolomics 2011; 7 (3):307 e 28.
50. Theodoridis G, Gika HG, Wilson ID. Mass
spectrometry-based holistic analytical approaches for
metabolite pro

ling of human
colon tissue. Rapid Commun Mass Spectrom 2009; 23 (4):
487 e 94.
37. Mal M, Koh PK, Cheah PY, Chan ECY. Metabotyping
of human colorectal cancer using two-dimensional gas
chromatography mass spectrometry. Anal Bioanal Chem
2012; 403 (2):483 e 93.
38. Weiss RH, Kim K. Metabolomics in the study of kidney
diseases. Nat Rev Nephrol 2012; 8 (1):22 e 33.
39. Willis CM, Church SM, Guest CM, Cook WA,
McCarthy N, Bransbury AJ, et al. Olfactory detection of
human bladder cancer by dogs: Proof of principle
study. Brit Med J 2004; 329 (7468):712 e 4.
40. Lindon JC, Nicholson JK, Holmes E, Antti H,
Bollard ME, Keun H, et al. Contemporary issues in
toxicology: The role of metabonomics in toxicology and
its evaluation by the COMET project. Toxicol Appl
Pharmacol 2003; 187 (3):137 e 46.
41. Lindon JC, Keun HC, Ebbels TMD, Pearce JMT,
Holmes E, Nicholson JK. The Consortium for Metabo-
nomic Toxicology (COMET): Aims, activities and
achievements. Pharmacogenomics 2005; 6 (7):691 e 9.
42. Zgoda-Pols JR, Chowdhury S, Wirth M, Milburn MV,
Alexander DC, Alton KB. Metabolomics analysis
reveals elevation of 3-indoxyl sulfate in plasma and
brain during chemically-induced acute kidney injury in
mice: Investigation of nicotinic acid receptor agonists.
Toxicol Appl Pharmacol 2011; 255 (1):48 e 56.
43. Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M,
Milburn MV, et al. Untargeted metabolomic pro

ling in systems biology studies. Mass
Spectrom Rev 2011; 30 (5):884 e 906.
51. Viswanathan CT, Bansal S, Booth B, DeStefano AJ,
Rose MJ, Sailstad J, et al. Workshop/conference
report d Quantitative bioanalytical methods validation
and implementation: Best practices for chromato-
graphic and ligand binding assays. AAPS J 2007; 9 (1):
E30 e 42.
52. Want E, Masson P. Processing and Analysis of GC/
LC-MS-Based Metabolomics Data, Metabolic Pro ling:

Methods and Protocols . New York: Humana Press; 2011.
p. 277 e 98.
53. van Den Dool H, Kratz PD. A generalization of the
retention index system including linear temperature
programmed gas-liquid partition chromatography.
J Chromatog A 1963; 11 (C):463 e 71.
54. Kind T, Wohlgemuth G, Lee do Y, Lu Y, Palazoglu M,
Shahbaz S, et al. FiehnLib: mass spectral and retention
index libraries for metabolomics based on quadrupole
and time-of- ight gas chromatography/mass spec-

trometry. Anal Chem 2009; 81 (24):10038 e 48.
55. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R,
Kochhar S, Macdonald IA, et al. Large-scale human
metabolomics studies: A strategy for data (pre-)
processing and validation. Anal Chem 2006; 78 (2):
567 e 74.
56. Steuer R, Morgenthal K, Weckwerth W, Selbig J. A
gentle guide to the analysis of metabolomic data.
Methods Mol Biol 2007; 358 :105 e 26.
57. Fiehn O, Kind T. Metabolite Pro

ling as

brate-induced toxicology in
Fischer 344 male rats. Toxicol Pathol 2009; 37 (4):521 e 35.
44. Theodoridis G, Gika HG, Wilson ID. Mass
spectrometry-based holistic analytical approaches for
metabolite pro

an evaluative tool of feno

ling in systems biology studies. Mass
Spectrom Rev 2011; 30 (5):884 e 906.
45. Kamleh MA, Ebbels TMD, Spagou K, Masson P,
Want EJ. Optimizing the use of quality control samples
for signal drift correction in large-scale urine metabolic
pro

ling in Blood Plasma.
Metabolomics: Methods and Protocols . Totowa: Humana
Press; 2006. p. 3 e 17.
58. Scholz M, Gatzek S, Sterling A, Fiehn O, Selbig J.
Metabolite

ling studies. Anal Chem 2012; 84 (6):2670 e 7.

'

46. D Autry W, Wolfs K, Yarramraju S, Schepdael AV,

Hoogmartens J, Adams E. Characterization and
improvement of signal drift associated with electron

fingerprinting: detecting biological features